Related Experiment Video
Updated: Nov 20, 2025

LINE-1 Methylation Analysis in Mesenchymal Stem Cells Treated with Osteosarcoma-Derived Extracellular Vesicles
Published on: February 1, 2020
ROR2 Is Epigenetically Regulated in Endometrial Cancer
Dongli Liu1, Luis Enriquez1, Caroline E Ford1
1Gynaecological Cancer Research Group, Lowy Cancer Research Centre, School of Women's and Children's Health, Faculty of Medicine, University of New South Wales, Sydney, NSW 2052, Australia.
The Wnt signaling receptor ROR2 acts as a tumor suppressor in endometrial cancer (EC). Epigenetic silencing via promoter methylation correlates with reduced ROR2 expression and poorer outcomes, suggesting ROR2 as a potential diagnostic and therapeutic target for EC.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- The Wnt signaling receptor ROR2 is implicated in various cancers, but its specific role in endometrial cancer (EC) is not fully understood.
- Understanding ROR2's function is crucial for identifying potential therapeutic strategies in EC.
Purpose of the Study:
- To investigate the role of ROR2 in endometrial cancer (EC).
- To elucidate the mechanism behind altered ROR2 expression in EC.
- To assess ROR2 as a potential diagnostic or therapeutic candidate for EC.
Main Methods:
- Analysis of ROR2 mRNA expression and clinicopathological parameters in TCGA-UCEC and GEO datasets.
- Assessment of ROR2 promoter methylation in EC cell lines and clinical samples using COBRA and BGS.
- Functional studies involving ROR2 overexpression in EC cell lines to evaluate effects on invasion and epithelial-mesenchymal transition (EMT) markers.
Main Results:
- Reduced ROR2 expression and promoter methylation correlated with shorter overall survival (OS), higher grade, and serous subtype in EC cohorts.
- ROR2 was epigenetically silenced by promoter methylation in both EC patient samples and cell lines.
- ROR2 restoration in EC cells significantly reduced invasion and altered EMT markers, indicating a tumor-suppressive role.
Conclusions:
- ROR2 functions as a tumor suppressor in endometrial cancer.
- Epigenetic silencing of ROR2 via promoter methylation is associated with EC progression.
- ROR2 represents a promising diagnostic and therapeutic target for endometrial cancer.
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Mitogens and the Cell Cycle

